Ian Karp | VP, Investor and Public Relations |
Michael Kauffman | CEO |
Sharon Shacham | President and Chief Scientific Officer |
Mike Mason | CFO |
John Demaree | Chief Commercial Officer |
Christopher Primiano | Chief Business Officer and General Counsel |
Jatin Shah | Chief Medical Officer |
Jonathan Chang | SVB Leerink |
Maury Raycroft | Jefferies |
Brian Abrahams | RBC Capital Markets |
Eric Joseph | J.P. Morgan |
David Lebowitz | Morgan Stanley |
Michael Ulz | Robert W. Baird |
Edward White | H.C. Wainwright |
Peter Lawson | Barclays Capital |
Good afternoon. My name is Kate, and I will be your conference operator today. At this time, I would like to welcome everyone to Karyopharm Therapeutics' Third Quarter 2020 Financial Results Conference Call. [Operator Instructions] Please be advised that the call is being recorded by the company's request. I would now like to turn the call over to Mr.